However, neither albumin nor the UAR or ACR predicted the risk of HF‐related rehospitalization (albumin Q1 vs. Q4: HR = 1.117; 95% CI .678–1.842; p = .664 / UAR Q4 vs. Q1: HR = 1.589; 95% CI .922–2.738; p = .095 / ACR Q1 vs. Q4: HR = 1.112; 95% CI .624–1.981; p = .720). The gene discussed is ALB; the disease is hydrops fetalis.